TITLE

Homeopathy for Childhood and Adolescence Ailments: Systematic Review of Randomized Clinical Trials

AUTHOR(S)
Altunç, Umut; Pittler, Max H.; Ernst, Edzard
PUB. DATE
January 2007
SOURCE
Mayo Clinic Proceedings;Jan2007, Vol. 82 Issue 1, p69
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
OBJECTIVE: To assess the evidence of any type of therapeutic or preventive intervention testing homeopathy for childhood and adolescence ailments. METHODS: Systematic literature searches were conducted through January 2006 in MEDLINE, EMBASE, AMED, CINAHL, Cochrane Central, British Homeopathic Library, ClinicalTrials.gov, and the UK National Research Register. Bibliographies were checked for further relevant publications. Studies were selected according to predefined inclusion and exclusion criteria. All double-blind, placebo-controlled randomized clinical trials of any homeopathic intervention for preventing or treating childhood and adolescence ailments were included. According to the classification of the World Health Organization, the age range defined for inclusion was 0 to 19 years. Study selection, data extraction, and assessment of methodological quality were performed independently by 2 reviewers. RESULTS: A total of 326 articles were identified, 91 of which were retrieved for detailed evaluation. Sixteen trials that assessed 9 different conditions were included in the study. With the exception of attention-deficit/hyperactivity disorder and acute child. hood diarrhea (each tested in 3 trials), no condition was assessed in more than 2 double-blind randomized clinical trials. The evidence for attention-deficit/hyperactivity disorder and acute child. hood diarrhea is mixed, showing both positive and negative results for their respective main outcome measures. For adenoid vegetation, asthma, and upper respiratory tract infection each, 2 trials are available that suggest no difference compared with placebo. For 4 conditions, only single trials are available. CONCLUSION: The evidence from rigorous clinical trials of any type of therapeutic or preventive intervention testing homeopathy for childhood and adolescence ailments is not convincing enough for recommendations In any condition.
ACCESSION #
23737587

 

Related Articles

  • Homeopathy Significantly Improves Attention.  // Homeopathy Today;Sep/Oct2005, Vol. 25 Issue 5, p10 

    Presents results of a controlled trial on the positive effects of homeopathy in children with attention deficit hyperactivity disorder (ADHD). Conduction of a neuro-psychological test to ADHD children prior to the homeopathic treatment; Efficacy of homeopathy in treating ADHD; Details on the...

  • Ritalin-free kids. Reichenberg-Ullman, Judyth; Ullman, Robert // Mothering;Apr-Jun97, Issue 83, p78 

    Provides information about Attention Deficit Disorder (ADD). What is ADD; Problems associated with ADD; How ADD affect children's behavior; What causes ADD; Ritalin as a solution to ADD; Homeopathic approach to ADD; More.

  • Homeopathy for Attention-Deficit/Hyperactivity Disorder: A Pilot Randomized-Controlled Trial. Jacobs, Jennifer; Williams, Anna-Leila; Girard, Christine; Njike, Valentine Yanchou; Katz, David // Journal of Alternative & Complementary Medicine;Oct2005, Vol. 11 Issue 5, p799 

    Objectives: The aim of this study was to carry out a preliminary trial evaluating the effectiveness of homeopathy in the treatment of attention-deficit/hyperactivity disorder (ADHD). Design: This work was a randomized, double-blind, placebo-controlled trial. Settings/Location: This study was...

  • Shire's Adderall XR proves effective in treating adolescent ADHD.  // PharmaWatch: CNS;December2004, Vol. 3 Issue 12, p12 

    Highlights the Shire Pharmaceuticals Group's report that its attention-deficit hyperactivity disorder (ADHD) drug Adderall XR proved effective and generally well tolerated for adolescents in a long-term study. Data from a four-week placebo-controlled trial with Adderall XR, an extended release,...

  • Development of ICF Core Sets to standardize assessment of functioning and impairment in ADHD: the path ahead. Bölte, Sven; Schipper, Elles; Holtmann, Martin; Karande, Sunil; Vries, Petrus; Selb, Melissa; Tannock, Rosemary // European Child & Adolescent Psychiatry;Dec2014, Vol. 23 Issue 12, p1139 

    In the study of health and quality of life in attention deficit/hyperactivity disorder (ADHD), it is of paramount importance to include assessment of functioning. The International Classification of Functioning, Disability and Health (ICF) provides a comprehensive, universally accepted framework...

  • MORE RESEARCH ON HOMOEOPATHY. Medhurst, Robert // Journal of the Australian Traditional-Medicine Society;Sep2003, Vol. 9 Issue 3, p141 

    Examines a number of positive trials of homeopathy. Individualized homeopathic therapy for male infertility; Homeopathy in HIV infection; Controlled double-blind study of a homeopathic sinusitis medication; Reduction of muscle soreness with Arnica montana; Efficacy of a homeopathic preparation...

  • Buspirone versus Methylphenidate in the Treatment of Children with Attention- Deficit/ Hyperactivity Disorder: Randomized Double-Blind Study. Mohammadi, Mohammad-Reza; Hafezi, Poopak; Galeiha, Ali; Hajiaghaee, Reza; Akhondzadeh, Shahin // Acta Medica Iranica;2012, Vol. 50 Issue 11, p723 

    A recent randomized clinical trial showed buspirone efficacy in the treatment of attention deficit/ hyperactivity disorder (ADHD) in children. However, results from a recent multi-site controlled clinical trial of transdermal buspirone failed to separate it from placebo in a large sample of...

  • Comparative Short term Efficacy and Tolerability of Methylphenidate and Atomoxetine in Attention Deficit Hyperactivity Disorder. GARG, JASMIN; ARUN, PRITI; CHAVAN, B. S. // Indian Pediatrics;Jul2014, Vol. 51 Issue 7, p550 

    Objective: To compare the short term efficacy and tolerability of methylphenidate and atomoxetine in children with Attention deficit hyperactivity disorder (ADHD). Design: Open label randomized parallel group clinical trial. Setting: Child Guidance Clinic of a tertiary care hospital of Northern...

  • Risk of Serious Cardiovascular Problems with Medications for Attention-Deficit Hyperactivity Disorder. Martinez-Raga, Jose; Knecht, Carlos; Szerman, Nestor; Martinez, María I. // CNS Drugs;2013, Vol. 27 Issue 1, p15 

    Attention-deficit hyperactivity disorder (ADHD) is a chronic neurodevelopmental disorder characterized by persistent symptoms of inattention, hyperactivity and/or impulsivity. The proportion of patients diagnosed with ADHD receiving pharmacological treatments has increased enormously in recent...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics